ClinicalTrials.Veeva

Menu
T

The Clinical Research Center | St. Louis, MO

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

fluticasone propionate
azelastine hydrochloride
HFA
Ciclesonide Hydrofluoroalkane
Racemic Albuterol
azelastine Hcl
azelastineHcl
Levalbuterol
azelastine HCl
NOC-110

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 22 total trials

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults with Refractory or Unexplained Chronic Cough (ASPIRE)

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Enrolling
Refractory or Unexplained Chronic Cough
Drug: NOC-110
Other: Placebo

Trial sponsors

Meda Pharmaceuticals logo
Sumitomo Pharma logo
A
Allergy Therapeutics logo
A
F
MedImmune logo
N
Novartis logo
Novartis logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems